Bruno Squarcio Fernandes Sanches
YOU?
Author Swipe
View article: Empirical Rescue Eradication Therapy for <scp> <i>Helicobacter pylori</i> </scp> Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on <scp> <i>H. pylori</i> </scp> Management (Hp‐ <scp>BrazilReg</scp> )
Empirical Rescue Eradication Therapy for <span> <i>Helicobacter pylori</i> </span> Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on <span> <i>H. pylori</i> </span> Management (Hp‐ <span>BrazilReg</span> ) Open
Background The effectiveness of anti ‐ H. pylori treatment diminishes with therapy failure, making regional performance understanding crucial. Objective To evaluate the effectiveness of empirical therapy in second‐line and subsequent treat…
View article: PREVALENCE OF HELICOBACTER PYLORI INFECTION AMONG GASTROENTEROLOGISTS AND GASTROENDOSCOPISTS IN BRAZIL
PREVALENCE OF HELICOBACTER PYLORI INFECTION AMONG GASTROENTEROLOGISTS AND GASTROENDOSCOPISTS IN BRAZIL Open
Background: Most Helicobacter pylori (H. pylori) infections are acquired in childhood. It remains uncertain whether gastroenterologists involved in endoscopic procedures face an increased occupational risk of H. pylori. Objective: To deter…
View article: Determinação molecular de resistência genotípica primária do helicobacter pylori à claritromicina e fluoroquinolonas em amostras gástricas obtidas por endoscopia digestiva alta no Brasil
Determinação molecular de resistência genotípica primária do helicobacter pylori à claritromicina e fluoroquinolonas em amostras gástricas obtidas por endoscopia digestiva alta no Brasil Open
INTRODUCAO: Alem da aderencia incompleta ao tratamento, o principal fator associado a falha terapeutica no tratamento de Helicobacter pylori (HP) e a resistencia bacteriana aos antimicrobianos, adquirida principalmente por mutacoes genetic…
View article: MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION
MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION Open
Background - Antimicrobial resistance is the major factor leading to eradication failure in H. pylori treatment. Molecular tests are useful to detect genetic mutations predictive of clarithromycin and fluoroquinolones resistance. Knowledge…
View article: Detection of<i>Helicobacter pylori</i>resistance to clarithromycin and fluoroquinolones in Brazil: A national survey
Detection of<i>Helicobacter pylori</i>resistance to clarithromycin and fluoroquinolones in Brazil: A national survey Open
The H. pylori clarithromycin resistance rate in Brazil is at the borderline (15%-20%) for applying the standard triple therapy. The fluoroquinolone resistance rate (13.5%) is equally concerning.